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Background: Irritable bowel syndrome (IBS) and functional abdominal pain (syndrome) (FAP(S)) are common pediatric
disorders, characterized by chronic or recurrent abdominal pain. Treatment is challenging, especially in children with
persisting symptoms. Gut-directed hypnotherapy (HT) performed by a therapist has been shown to be effective in
these children, but is still unavailable to many children due to costs, a lack of qualified child-hypnotherapists and
because it requires a significant investment of time by child and parent(s). Home-based hypnotherapy by means of
exercises on CD has been shown effective as well, and has potential benefits, such as lower costs and less time
investment. The aim of this randomized controlled trial (RCT) is to compare cost-effectiveness of individual HT
performed by a qualified therapist with HT by means of CD recorded self-exercises at home in children with IBS or FAP(S).
Methods/Design: 260 children, aged 8-18 years with IBS or FAP(S) according to Rome III criteria are included in this
currently conducted RCT with a follow-up period of one year. Children are randomized to either 6 sessions of individual
HT given by a qualified therapist over a 3-month period or HT through self-exercises at home with CD for 3 months.
The primary outcome is the proportion of patients in which treatment is successful at the end of treatment and after
one year follow-up. Treatment success is defined as at least 50% reduction in both abdominal pain frequency and
intensity scores. Secondary outcomes include adequate relief, cost-effectiveness and effects of both therapies on
depression and anxiety scores, somatization scores, QoL, pain beliefs and coping strategies.
Discussion: If the effectiveness of home-based HT with CD is comparable to, or only slightly lower, than HT by a
therapist, this treatment may become an attractive form of therapy in children with IBS or FAP(S), because of its
low costs and direct availability.
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Irritable bowel syndrome (IBS) and functional abdominal
pain (syndrome) (FAP(S)) are functional gastrointestinal
disorders (FGIDs) that are characterized by chronic or
recurrent abdominal pain in absence of an underlying
organic disorder causing the symptoms [1]. These disor-
ders affect approximately 20% of children in Western
countries and are also prevalent in Asian countries such
as Sri Lanka and China, affecting 12,5 to 20% of school-
aged children [2-4]. Altered bowel movements and/or
relief of abdominal pain after defecation are present in
children with IBS, while defecation pattern is normal in
children with FAP(S) [1].
Quality of life (QoL) is significantly impaired in most
children with IBS or FAP(S): QoL scores are lower com-
pared to healthy peers and comparable to children with
inflammatory bowel diseases [5]. Children with IBS or
FAP(S) have an increased risk for anxiety and/or depres-
sion and have high rates of school absenteeism [6,7].
Health care costs associated with these FGIDs are consid-
erable. Diagnostic workup for a child with IBS or FAP(S)
in the United States costs approximately 6000 dollar.
The exact costs of treatment of these children are not
known, but are also likely to be significant since treat-
ment of adult patients with IBS costs more than $20 bil-
lion per year [8,9].
Pathophysiological mechanisms causing IBS and FAP(S)
are not fully clarified to this date, but these FGIDs are
thought to be a result of a complex interplay of multiple
genetic, psychosocial and physiological factors [10].
Standard medical treatment of IBS and FAP(S) consists
of a combination of dietary advice, education and pharma-
cological therapy, such as pain medication, laxatives, anti-
diarrheal medication and antispasmodics [11,12]. Despite
these treatments, a significant part of children with IBS
or FAP(S) continues to experience symptoms, even into
adulthood [13].
In the last 30 years, multiple trials have demonstrated
that gut-directed hypnotherapy (HT) is an effective ther-
apy in patients with IBS [14-25]. In gut-directed HT, a
hypnotic state is induced and a patient is guided to re-
spond to suggestions towards control and normalization
of gut functioning, stress reduction and ego-strengthening
[26]. Adult IBS-trials have shown that patients receiving
HT report significantly lower levels of abdominal pain and
symptom scores compared to patients receiving various
control treatments. In addition, these effects of gut-
directed HT were shown to be long lasting, up to seven
years after treatment [20-22]. Gut-directed HT by a
therapist has also been studied in children with IBS or
FAP(S) and, in accordance with results of adult studies,
these trials show HT to be highly effective compared to
standard care [23-25] with persisting positive effects
after a period of approximately five years [27]. Althoughthese trials show that gut-directed HT is a valuable thera-
peutic option, especially in children with persisting symp-
toms, it is still unavailable to many children with IBS or
FAP(S), because gut-directed HT performed by a therapist
is costly and frequently not reimbursed by health insurance
companies. In addition, the number of well-trained child-
hypnotherapists is very limited in most countries and the
treatment requires a significant investment of both children
and parent(s), since visits to the hypnotherapist may cause
work and school absences. Van Tilburg et al. studied the ef-
ficacy of home-based HT using self-exercises on compact
disc (CD) and showed that approximately two thirds of
children receiving this home based treatment responded
well with >50% reduction in abdominal pain scores [28].
Potential benefits of this treatment at home include that
it is less time consuming and less costly compared to
HT with a therapist.
Therefore, the primary aim of this study is to compare
efficacy of individual HT performed by a qualified ther-
apist with HT by means of CD recorded self-exercises at
home in children with IBS or FAP(S). Secondary aims
include adequate relief, the cost-effectiveness, effects on
depression and anxiety scores, somatization scores, QoL,
pain beliefs and coping strategies.
Methods/Design
Study design and population
A randomized controlled trial (RCT) with 1 year follow-
up is currently conducted to evaluate the efficacy of indi-
vidual HT performed by a qualified therapist versus HT at
home with self-exercises on CD in children with IBS or
FAP(S). This study has been designed in line with the
methodological recommendations established by the
Rome II consensus on ‘Design of treatment trials for
gastrointestinal disorders’ [29]. Nine hospitals through-
out the Netherlands participate in this RCT. Children
are recruited at the outpatient clinic of the department
of pediatric gastroenterology of the academic medical
centers in Amsterdam and Maastricht and at the out-
patient clinic of the departments of pediatrics of the
Medical Center Alkmaar, the Flevo Hospital Almere, the
Amphia Hospital Breda, St. Antonius Hospital Nieuwe-
gein, the Maasstad Hospital in Rotterdam, the Maxima
Medical Center Veldhoven and the Isala Clinics Zwolle.
This RCT has been reviewed and approved by the med-
ical ethics committees of all participating hospitals and
has been registered in the Dutch Trial Register number
NTR2725. It is granted by the Netherlands Organization
for Health Research and Development, ZonMW.
A total of 260 children aged 8-18 years diagnosed with
IBS, FAP or FAPS according to the Rome III criteria are
included in this RCT [1]. Before inclusion, all patients
undergo routine laboratory testing to exclude underlying
organic disorders: complete blood cell count, C-reactive
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ferase (AST), glutamyltransferase (GGT), creatinine, total
bilirubin, amylase, celiac screening (anti-transglutaminase
antibodies and IgA), urinalysis, stool parasite analysis and
H pylori antigens in stool. The need for further diagnostic
testing is left to the discretion of the treating physician.
Verbal and written information about the study is
given by the pediatrician/pediatric gastroenterologist and
patients are asked to participate in this RCT if all criteria
are met. Subsequently, verbal and written informed con-
sent is obtained from the child and/or both parents. If
the child or parent(s) decide not to participate in this
RCT, the reason(s) for not participating are documented,
if they want to reveal these.
Inclusion and exclusion criteria
Inclusion criteria
(1) Diagnosis of irritable bowel syndrome (IBS) or
functional abdominal pain (syndrome) (FAP(S))
according to Rome III criteria [1]
(2) Age 8-18 years at inclusion
Exclusion criteria
(1) Concomitant organic gastrointestinal disease
(2) Treatment by another health care professional
for abdominal pain symptoms
(3) Previous hypnotherapy
(4) Mental retardation
(5) Insufficient knowledge of the Dutch language
After obtaining informed consent, children are
randomly allocated using a computerized random-
number generator for concealment, to either individ-
ual hypnotherapy given by a qualified therapist or
home-based therapy with hypnotherapy exercises on
CD. Randomization is performed on a 1:1 basis with
varying block sizes of 2, 4 and 6. Stratification is
based on the including hospital and school level
(primary/secondary school).Interventions
The HT protocol used in this RCT is based on the Man-
chester protocol for gut-directed HT adapted for chil-
dren [30] and is comparable to the treatment protocol
used in a previous RCT on gut-directed HT in the
Netherlands [24]. Hypnotherapy consists of exercises on
general relaxation, control of abdominal pain and gut
functioning and ego-strengthening suggestions. Several
scripts for the exercises used in this RCT are based on
scripts used in the van Tilburg et al. trial [28]. Given the
nature of HT, blinding of patients and health care pro-
fessionals involved in the treatment of the participants
is not possible.Individual hypnotherapy by a therapist
Individual HT consists of six sessions of 50-60 minutes
over a period of three months and is carried out by 11
hypnotherapists affiliated to the recruiting hospitals. All
participating hypnotherapists are qualified and have many
years of experience in performing HT in children. They
have been trained in working with the treatment protocol
and instructed to use the same scripts that are used in the
CD group, but are allowed to adapt contents and order of
these scripts to the child’s interests and specific issues that
may come up during therapy. The same protocol is used
for children of all ages, but the language used is adapted
to the child’s developmental age.
In the first HT session, therapists take a full history.
Furthermore, it is explained to both child and parent(s)
what hypnotherapy is and how it can help in reducing
chronic abdominal pain.
Also, children and parent(s) are instructed not to talk
about the pain anymore. In the same session, an exer-
cise on breathing and progressive relaxation is intro-
duced in which children imagine floating on a big
cloud. Positive suggestions for decreasing discomfort
are given, such as making their hands warm and to
place both hands on their belly, imagining the warmth
spreading through their abdomen. In the second ses-
sion, the exercise on progressive relaxation is repeated.
Furthermore, an exercise focusing on reduction of
anxiety and stress is introduced (‘the favorite place
exercise’). In session three, an exercise on ego-
strengthening is introduced (‘the rainbow planet exer-
cise’ for children attending primary school; ‘the air bal-
loon exercise’ for children in secondary school). In this
hypnosis exercise children choose colors from the rain-
bow for different needs, for example health, tranquility,
courage or confidence. During the fourth session the
‘beach without worries exercise’ is introduced, in
which children are encouraged to release stress and
again, ego-strengthening suggestions are made. In the
fifth session, children do ‘the slide exercise’ in which chil-
dren visualize sitting on a slide. Suggestions on reduction
of anxiety and stress and ego-strengthening suggestions
are given as well as visualizations of a well working digest-
ive system with food sliding through the bowel in a com-
fortable way. In the last session, evaluation of the previous
three months will take place. In addition, remaining issues
related to the abdominal pain may be addressed and previ-
ous exercises are repeated, depending on the needs of the
individual patient. Children are advised to keep practicing
the HT exercises at home on a regular basis. After the first
HT-session all children in the HT-group receive a CD
containing standard scripts of all exercises used and they
are instructed to listen to the exercises or to practice self-
hypnosis on a daily basis. Furthermore, they are encour-
aged to practice the breathing exercise a few times a day.
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Children assigned to the CD-group are visited at home
by a specially trained research nurse. During this visit
the research nurse explains the nature of HT and the exer-
cises to the child and parent(s) and children receive the
CD together with an instruction leaflet. In addition, chil-
dren and parent(s) are instructed not to talk about the ab-
dominal pain anymore. Children are asked to do the first
exercise of the CD during this visit, to check whether the
child understands the given instructions. The previous
trial on home-based treatment has demonstrated that this
method is very easy to understand and use [28]. The CD
contains five standard scripts of the hypnosis exercises,
which are identical to the exercises used by the hypno-
therapists. These exercises consist of one exercise on
breathing and progressive relaxation and four
visualization exercises: ‘the favorite place exercise’, ‘the
rainbow planet/air balloon exercise’ (depending on devel-
opmental age), ‘the beach without worries exercise’ and
‘the slide exercise’). Two separate CDs are used to make
sure that the language used is adapted to the child’s de-
velopmental age: one CD for children visiting primary
school and one CD for children visiting secondary
school. Prior to this RCT, the CD has been tested by
three children with chronic abdominal pain and no
changes were required. Children are instructed to listen
to the hypnosis exercises at least five times a week over
a period of three months. Furthermore, they are encour-
aged to practice the breathing exercise a few times a
day. The frequency of listening to the CD will be re-
corded by the participants in their instruction leaflet.
The research nurse will make phone calls to the chil-
dren after 4 and 8 weeks of treatment to stimulate treat-
ment compliance.
Co-interventions
All children participating in this RCT are seen by their
pediatrician or pediatric gastroenterologist after three
months of HT to evaluate the effects of HT and to pro-
vide standard medical care if considered necessary. In
addition, children will also visit their physician after
6 months of follow up if necessary.
Outcomes
Outcomes are measured at baseline (T0), after 3 months
of therapy (T1) and at 6 and 12 months follow-up after
the end of therapy (T2, T3).
Outcomes are recorded by patients and/or parents at
home. At inclusion, a questionnaire on demographics and
clinical features is filled out by the treating physician. An
overview of the assessments made in this RCT is shown
in Table 1.
1. Abdominal painThe main goal of treatment in IBS/FAP(S) patients is a
reduction in levels of abdominal pain.
Abdominal pain is assessed with a diary, in which chil-
dren record the frequency and intensity of abdominal
pain episodes on seven consecutive days [14,24,27,31].
Pain frequency is recorded in minutes of abdominal pain
per day and is scored as 0 when there was no pain, 1 if
children experience 1-30 minutes of pain, 2 for 31-120
minutes of pain and 3 if abdominal pain lasts more than
120 minutes. A pain frequency score (PFS) is subse-
quently calculated by summing the scores of the seven
days, giving a maximum PFS of 21 [24,27,31]. Pain in-
tensity is scored using an affective facial scale with faces
ranging from showing no pain at all (face A) to the most
severe pain (face I). Scores on the facial scale are trans-
ported to a daily 0-3 score. No abdominal pain is scored
as 0, faces A-C are scored as 1, faces D-F score 2 and
faces G-I score as 3. Again, scores of seven days are to-
taled giving a pain intensity score (PIS), with a ma-
ximum of 21 [24,27,31].
The primary outcomes in this RCT are the proportion
of patients in which treatment is successful at the end of
treatment and the proportion of successfully treated pa-
tients after 1 year follow-up. Treatment success is de-
fined as at least 50% reduction in both abdominal pain
frequency and intensity scores.
2. Hypnotic susceptibility
Hypnotic susceptibility is defined as a generalized ten-
dency to respond to hypnosis and hypnotic suggestions
[32] and is assessed using a Dutch translation of the
Stanford hypnotic clinical scale for children [33]. It is
administered by the treating hypnotherapist in children
assigned to the HT-group and by the research nurse in
children assessed to the CD-group. The Stanford hyp-
notic clinical scale for children consists of seven items.
Scores are based on assessment of the child’s behavior
and experiences which are verbally reported to the
therapist/research nurse. Scores on this scale range from
0 to 7 and higher scores represent higher hypnotic
susceptibility.
3. Treatment expectations
Expectations about the response to treatment are
assessed for the child, mother and father separately. Child
and parents are asked whether they expect the child to
improve with treatment and this question is scored on a
11-point scale (0 = not at all; 10 = complete recovery). It is
also assessed whether they have a (strong) preference for
HT with a therapist or home-based with CD.
4. Depression and anxiety
Table 1 Overview of outcomes
Outcome Instrument T0 4 wks 8 wks T1 T2 T3
Abdominal pain Abdominal pain dairies X X X X X X
Hypnotic susceptibility Stanford hypnotic clinical scale for children X
Treatment expectations Self-designed questionnaire for child and parents X
Depression and anxiety Revised Anxiety and Depression Scale-short version (RCADS-25) X X X X
Somatization Children’s Somatization Inventory (CSI) X X X X
Health related quality of life KIDSCREEN-52 X X X X
Pain beliefs Pain Beliefs Questionnaire (PBQ) X X X X
Coping strategies Children’s Coping Strategies Checklist-revision 1 (CCSC-R1) X X X X
Cost-effectiveness/cost-utility Health Utility Index Mark 3 (HUI-3) & costs-questionnaire X X X X
Adequate relief Binary question on adequate relief X X X
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sion Scale (RCADS-25) is a valid and reliable instrument
for the Dutch population to assess symptoms of depres-
sion and anxiety [34]. It contains five subscales measuring
symptoms of generalized anxiety disorders, separation
anxiety disorder, social phobia, panic disorder and major
depressive disorder. Each subscale consists of five items,
which are scored on a 0 to 3 scale (0 = never; 3 = always).
A total score on anxiety is calculated by summing scores
on the four individual anxiety scales.
5. Somatization
Child somatization scores are assessed using the Dutch
version of the Children’s Somatization Inventory (CSI),
which has been shown to be a reliable and valid self-
report instrument in children and adolescents [35]. It
contains 35 items on the extent to which children expe-
rienced somatic symptoms in the previous two weeks.
Items are scored on a 5-point scale, ranging from 0
(=not at all) to 4 (=a whole lot). A total score is calculated
by summing all 35 individual items and higher scores re-
flect a higher intensity of somatic complaints experienced
by the child. A separate CSI-score for non-gastrointestinal
(GI) symptoms can be calculated by leaving out 7 items
on GI-complaints: nausea, constipation, diarrhea, epigas-
tric and abdominal pain, vomiting and bloating. To assess
GI-complaints other than abdominal pain, items on all
GI-symptoms but abdominal pain are summed.
6. Health related quality of life
The KIDSCREEN-52 questionnaire is a frequently used
and reliable instrument to measure health related Qol in
children and adolescents and has been validated in Dutch
pediatric patient groups [36,37]. It contains items on ten
dimensions of health related QoL: physical well-being,
psychological well-being, moods and emotions, self-
perception, autonomy, relations with parents and homelife, social support and peers, school environment, social
acceptance (bullying) and financial resources. A 5-point
Likert scale is used to score each item. Rasch scores for
each individual dimension are computed from the individ-
ual items and these are transformed into T-values. Higher
T-values indicate a better health related QoL and well-
being.
7. Pain beliefs
Negative and positive beliefs that children have about
their abdominal pain are assessed using the Pain Beliefs
Questionnaire (PBQ). A Dutch translation of the PBQ,
which is reliable and validated in children and adoles-
cents is used [38,39]. The PBQ consists of 32 items
scored on a 5-point Likert scale. Negative beliefs can be
divided into five subscales, namely condition frequency,
condition duration, condition seriousness, episode spe-
cific intensity and episode specific duration. The nega-
tive beliefs scale is calculated by summing all 20 items
on negative beliefs. The other 12 items assess problem
focused coping potential (PFCP) and emotion focused
coping potential (EFCP). The PFCP and EFCP scales are
computed by averaging the 6 items belonging to both
scales. Higher scores on a scale indicate that a child has
such thoughts more frequently.
8. Coping strategies
The Dutch version of the Children’s Coping Strategies
Checklist-revision 1 (CCSC-R1) is used to measure strat-
egies for coping with everyday problems [40,41]. The
CCSC-R1 includes 54 items, all starting with the same
phrase ‘if I have a problem…’ and all items are scored on
a 4-point Likert-scale (1 = never; 4 = always). This ques-
tionnaire has sound psychometric properties and com-
prises five dimensions: problem focused coping, positive
cognitive reframing, distraction strategies, avoidance
strategies and support seeking strategies. Scale scores on
Rutten et al. BMC Pediatrics 2014, 14:140 Page 6 of 8
http://www.biomedcentral.com/1471-2431/14/140all five dimensions are calculated by averaging the indi-
vidual items belonging to the five scales.
9. Cost-effectiveness/cost-utility
The Health Utility Index Mark 3 (HUI-3) is applied as
a multi-attribute utility measure of health status and will
be used in the cost-effectiveness and cost-utility analysis.
It is suitable for assessing children, but because children
may be too young to provide reliable and valid informa-
tion about their own health status, proxy measurements
are taken from parents [42-45]. The health utilities de-
rived from the HUI-3 have been anchored with 1 indi-
cating perfect health and 0 indicating death. Quality
adjusted life years (QALY) will be calculated by taking
the sum of the utility of health states over time by the
time in between successive measurements.
In addition to the HUI-3, the Dutch Health and Labor
Questionnaire (HLQ) has been adapted to the study set-
ting to measure the direct and indirect costs of health
care utilization, work absenteeism by parents, and school
absenteeism by children.
10. Adequate relief
Adequate relief has been shown to be a well validated
outcome measurement in trials on treatment for IBS
[46]. Parents are asked whether their child has adequate
relief of IBS-related abdominal pain or discomfort, using
a dichotomous scale (yes/no).
Statistical analysis
Two hundred and sixty children diagnosed with IBS or
FAP(S) will be included. The data will be analyzed fol-
lowing the intention to treat principle. The primary ana-
lyses will focus on the proportion of patients in both
treatment arms in which treatment was successful
(>50% reduction abdominal pain frequency and inten-
sity) at T1 and the proportion of patients in which treat-
ment was successful at T3. In addition, abdominal pain
levels will be compared in its continuous form using all
five moments of measurement during follow-up (after 4
and 8 weeks of treatment, at T1, T2 and T3). These data
will be analyzed using linear mixed models to account
for correlations of measurements within the same individ-
ual. Similar longitudinal, repeated measurement analyses
will be performed for the secondary outcomes including
depression and anxiety, somatization, health related Qol,
pain beliefs, coping strategies and adequate relief. Baseline
values will be incorporated in these analyses to adjust for
any imbalance at baseline despite randomization and to in-
crease precision by removing between-person variability.
Two explanatory subgroup analyses are planned to
evaluate whether there are indications that treatmenteffects differ between clinical subgroups. Children diag-
nosed with IBS will be compared to children with FAP(S).
Additionally, children in pre-puberty age (13 years or
younger) will be compared to older children, since our pre-
vious RCT showed that younger children showed a better
treatment response up till 6 months after treatment [24].
Economic evaluation will be performed from a societal
perspective. Cost-effectiveness and cost-utility ratios will
be calculated for the additional costs per extra patient
with at least 50% reduction of abdominal pain scores
and the additional costs per extra QALY.
Power
The primary analysis focuses on the proportion of patients
with at least 50% reduction in abdominal pain levels com-
pared to baseline at the end of therapy and after one year
of follow up. Based on previous trials, we made a conserva-
tive estimate of this percentage being around 75% in the
group receiving HT performed by a therapist. In the group
assigned to self-hypnosis with CD, we anticipated this
percentage to be marginally lower at 65%. In order to be
a reasonable alternative treatment, this percentage should
not become lower than 50% in the CD group. This non-
inferiority margin should be viewed in relation to success
rated with standard medical care of around 30-40% in pre-
vious trails [23,24,28]. Based on these expected propor-
tions and a non-inferiority margin at 50%, a total of 115
patients per group are needed to achieve a power of 80%
with a one-sided significance level of 5%. Since we expect
less than 10% drop-out, our aim is to include 130 patients
per group.
Discussion
To our knowledge, this is the first RCT comparing the
effectiveness of gut-directed HT performed by a quali-
fied therapist to home-based HT with self exercises in
CD in children with IBS or FAP(S). It has been designed
according to methodological recommendations on the
design of treatment trials for gastrointestinal disorders
and has several strengths [29]. A total of 260 children
with a Rome III diagnosis of IBS or FAP(S) are included
in this RCT, while previous pediatric trials on HT had
sample sizes up to 52 patients [23-25,28]. Generalizability
of the results of this trial will be increased, because we in-
clude both younger children and adolescents, patients
from urban and rural areas in the Netherlands and recruit
children from both academic centers and teaching hospi-
tals. In addition, children are followed for a period of
1 year after the end of therapy, to evaluate whether initial
effects are sustained over time. In contrast with our earlier
HT trial, in which all children were treated by the same
hypnotherapist [24], in this study eleven different hypno-
therapists are involved in the treatment of children with ab-
dominal pain. This will shed light on the influence of the
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outcomes, such as depression, anxiety and somatization, it
may become possible to predict response to HT, thereby
allowing clinicians to select children that are likely to
benefit from HT. A possible limitation of this study may
be the fact that children and parents are not blinded for
the received treatment, which is not possible due to the
nature of HT. Recording of outcome measures by chil-
dren and parents themselves at home, instead of recor-
ding of outcomes by a health care professional during a
visit to the hospital, however, reduces the risk of detec-
tion bias. In addition, the fact that symptoms of abdom-
inal pain are recorded for seven consecutive days has
the benefit that it corrects for individual variability of
symptoms over time. Response expectancies are known
to (partly) mediate effects of psychological treatments,
such as HT [47]. We therefore record expectancies
about HT from the child and both parents separately to
assess the magnitude of expectation bias. Another pos-
sible limitation of the design of this RCT may be the fact
that we did not include a third treatment arm with chil-
dren receiving standard medical care. This third treatment
group however was waived, since reviewers considered
it being not ethical to abstain children from treatment
with HT, because previous studies have shown HT to
be superior to standard medical care in this group of
patients [23,24,28].
If this RCT will show that the effectiveness of home-
based HT with CD is comparable to or only slightly lower
than HT by a therapist, this treatment may become an
attractive first line of treatment in children with IBS or
FAP(S). Since it presumably is less costly and less time-
consuming, it will benefit children, parents and society.
In addition, the large number of children with IBS and
FAP(S) combined with a shortage of qualified thera-
pists, causes long waiting lists nowadays. Home-based
HT can be started as soon as the diagnosis of IBS or
FAP(S) has been made, without dealing with these long
waiting lists. A potential scenario after this RCT might
be that a significant proportion of children with IBS or
FAP(S) can get this home-based treatment, prescribed
by their general practitioner. This may subsequently
lead to fewer referrals to pediatricians and/or pediatric
gastroenterologists, which would lead to an additional
decrease in health care costs. If this RCT indeed shows
these results, the next step will be implementation of
home-based HT into clinical care for children with IBS
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